These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2945406)

  • 1. The effect of phosphonoformic acid on wild type and mutant S49 cell lines.
    Albert DA; Gudas LJ
    Adv Exp Med Biol; 1986; 195 Pt B():185-9. PubMed ID: 2945406
    [No Abstract]   [Full Text] [Related]  

  • 2. Selection and characterization of mutant S49 T-lymphoma cell lines resistant to phosphonoformic acid: evidence for inhibition of ribonucleotide reductase.
    Albert DA; Gudas LJ
    J Cell Physiol; 1986 May; 127(2):281-7. PubMed ID: 2939095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of HIV-1 RNA-dependent DNA polymerase and cellular DNA polymerases alpha, beta and gamma by phosphonoformic acid and other drugs.
    Wondrak EM; Löwer J; Kurth R
    J Antimicrob Chemother; 1988 Feb; 21(2):151-61. PubMed ID: 2452149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of inhibition of Epstein-Barr virus replication by phosphonoformic acid.
    Datta AK; Hood RE
    Virology; 1981 Oct; 114(1):52-9. PubMed ID: 6269292
    [No Abstract]   [Full Text] [Related]  

  • 5. Observations on the phosphonoformic acid inhibition of RNA dependent DNA polymerases.
    Modak MJ; Srivastava A; Gillerman E
    Biochem Biophys Res Commun; 1980 Sep; 96(2):931-8. PubMed ID: 6158948
    [No Abstract]   [Full Text] [Related]  

  • 6. Induction of alkaline phosphatase and the glycoprotein hormone alpha subunit in HeLa cells by inhibitors of DNA polymerase.
    Cox GS; Park KH
    Arch Biochem Biophys; 1982 Jun; 216(1):234-46. PubMed ID: 6179479
    [No Abstract]   [Full Text] [Related]  

  • 7. [Action of ribamidyl and phosphonoformic acid on the reproduction of the HTLV-III retrovirus in vitro].
    Nesterchuk SL; Gribencha SV; Barinskiĭ IF; Zhadanov VM
    Vopr Virusol; 1987; 32(3):364-6. PubMed ID: 2960081
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of foscarnet on the cell kinetics of Madin-Darby canine kidney cells.
    Stenberg K; Skog S; Tribukait B
    Biochim Biophys Acta; 1983 Feb; 762(1):31-5. PubMed ID: 6219711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of hydroxyurea (HYU) resistant S49 T lymphoma cells.
    Albert DA; Gudas LJ
    Adv Exp Med Biol; 1986; 195 Pt B():305-9. PubMed ID: 3020910
    [No Abstract]   [Full Text] [Related]  

  • 10. Interaction of Epstein-Barr virus DNA polymerase with aphidicolin, phosphonoformate and 5'-GMP.
    Li JS; Cheng YC
    Virus Genes; 1988 Jul; 1(4):369-75. PubMed ID: 2852412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribonucleotide reductase activity and deoxyribonucleoside triphosphate metabolism during the cell cycle of S49 wild-type and mutant mouse T-lymphoma cells.
    Albert DA; Gudas LJ
    J Biol Chem; 1985 Jan; 260(1):679-84. PubMed ID: 2981227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of eucaryotic DNA polymerases by phosphonoacetate and phosphonoformate.
    Sabourin CL; Reno JM; Boezi JA
    Arch Biochem Biophys; 1978 Apr; 187(1):96-101. PubMed ID: 655729
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of HTLV-III/LAV replication by foscarnet.
    Sarin PS; Taguchi Y; Sun D; Thornton A; Gallo RC; Oberg B
    Biochem Pharmacol; 1985 Nov; 34(22):4075-9. PubMed ID: 2415134
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro recovery of resistant retrovirus isolates after exposure to phosphonoformate.
    Muratore O; Varnier OE; Raffanti SP; Schito GC
    Eur J Clin Microbiol; 1984 Oct; 3(5):447-9. PubMed ID: 6238823
    [No Abstract]   [Full Text] [Related]  

  • 15. Design and synthesis of phosphonoacetic acid (PPA) ester and amide bioisosters of ribofuranosylnucleoside diphosphates as potential ribonucleotide reductase inhibitors and evaluation of their enzyme inhibitory, cytostatic and antiviral activity.
    Manfredini S; Solaroli N; Angusti A; Nalin F; Durini E; Vertuani S; Pricl S; Ferrone M; Spadari S; Focher F; Verri A; De Clercq E; Balzarini J
    Antivir Chem Chemother; 2003 Jul; 14(4):183-94. PubMed ID: 14582847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of foscarnet on herpesvirus multiplication in cell culture.
    Schnürer J; Oberg B
    Arch Virol; 1981; 68(3-4):203-9. PubMed ID: 6268019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro inhibition of Herpesvirus sylvilagus by phosphonoacetic acid and phosphonoformate.
    Goodrich JM; Lee KW; Hinze HC
    Arch Virol; 1980; 66(3):261-4. PubMed ID: 6449917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human renal epithelial Na+/Pi cotransport by phosphonoformic acid.
    Yusufi AN; Szczepanska-Konkel M; Kempson SA; McAteer JA; Dousa TP
    Biochem Biophys Res Commun; 1986 Sep; 139(2):679-86. PubMed ID: 2945556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antiviral activity of phosphonoacetic acid, phosphonopropionic acid, and trisodium phosphonoformate hexahydrate against herpesvirus hominis type 1 and type 2 in vitro].
    Thiel KD; Wutzler P; Sprössig M; Bertram D
    Pharmazie; 1982 Aug; 37(8):608. PubMed ID: 6292963
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of cytomegalovirus late antigens by phosphonoformate.
    Wahren B; Oberg B
    Intervirology; 1980; 12(6):335-9. PubMed ID: 6244238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.